Evidence map›Paper›PMID 41847169›Full record

ArticleNeuro-oncology advances

Adult patient and caregiver perspectives on the impact of NF1-PN: Insights from a US qualitative survey.

Phioanh L Nghiemphu, Conrad L Cordova, Alyssa Bowling, Abby Crites, Xiaoqin Yang, Theresa Dettling

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Phioanh L NghiemphuDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles (P.L.N.).
Conrad L CordovaPatient author (C.L.C.).
Alyssa BowlingGlobal Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston (A.B.).
Abby CritesAdvisory & Brand Intelligence, IQVIA, Durham (A.C.).
Xiaoqin YangValue and Implementation Outcomes Research, Merck & Co., Inc, Rahway (X.Y.).
Theresa DettlingUS Health Economics and Outcomes Research, Alexion, AstraZeneca Rare Disease, Boston (T.D.).

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
NCI NIH HHS P50 CA211015
6 · The paper itself

Abstract

Background: Adults with neurofibromatosis type 1 and plexiform neurofibroma (NF1-PN) experience multiple clinical symptoms and diverse manifestations, which place a burden on patients and impact quality of life. This qualitative study aimed to improve understanding of disease burden, healthcare experience, and unmet needs of adults with NF1-PN in the United States, from patient and caregiver perspectives. Methods: Telephone interviews were conducted with adults who had a diagnosis of NF1-PN, or with caregivers, focusing on patient background, diagnosis, interactions with healthcare professionals, disease and symptom management, transition of care, and unmet needs. Results: The study included 11 adult patients with NF1-PN and 2 caregivers; 85% of patients were diagnosed in childhood. Patients lived with multiple conditions associated with NF1, including pain disorders, psychiatric disorders, and chronic migraines. NF1-PN impacted daily living, work, school, relationships, and mental and emotional health. Most patients (82%) transitioned from pediatric to adult care, although there was variability in the transition experience. Some dropped out of care (23%) due to various factors, including time constraints, physician location, financial insecurity, lack of insurance, and perception of no available treatments/cure. Medical management primarily comprised medications to relieve symptoms associated with NF1 manifestations. Respondents identified a need to be more informed about their care. Improved treatment options for NF1-PN are desired, particularly medications that stop or slow PN growth. Conclusions: The study demonstrated that NF1-PN has a profound impact on adult patients' lives. Several unmet needs exist for the adult population, including medications to treat the PN and its associated symptoms.

Indexed as

adultscaregiver perspectivesneurofibromatosis type 1patient perspectivesplexiform neurofibroma

Identifiers

PMID41847169
PMCPMC12990978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.